Etiology of severe pneumonia in Ecuadorian children

Sivani Jonnalagadda1, Oswaldo Rodríguez2, Bertha Estrella2,3

  • 1Center for Global Health and Development, Boston University School of Public Health, Boston, Massachusetts, United States of America.

Plos One
|February 10, 2017
PubMed

Insights

Community-acquired pneumonia in Ecuadorian children is frequently caused by respiratory syncytial virus (RSV) and influenza. Undernutrition is a key risk factor, highlighting the need for interventions and a potential RSV vaccine.

Area of Science:

  • Pediatric infectious diseases
  • Respiratory pathogen research
  • Etiology of community-acquired pneumonia

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of child morbidity and mortality in Latin America.
  • Etiological studies of pneumonia in Ecuador are limited.
  • This study investigated the causes of severe pneumonia in young children in Quito, Ecuador.

Purpose of the Study:

  • To determine the bacterial and viral etiology of severe community-acquired pneumonia in children aged 2-59 months in Ecuador.
  • To identify risk factors associated with specific respiratory pathogens.

Main Methods:

  • Observational study within a randomized clinical trial in Quito, Ecuador.
  • Analysis of nasopharyngeal and blood samples using polymerase chain reaction (PCR).
  • Evaluation of risk factors for identified respiratory pathogens.

Main Results:

  • Respiratory syncytial virus (RSV) was detected in 39.2% of children, human metapneumovirus (hMPV) in 17.5%, and adenovirus in 15.3%.
  • Streptococcus pneumoniae was found in 9.2% and Mycoplasma pneumoniae in 0.74%.
  • Younger age and underweight status were risk factors for RSV; maternal education and clinical signs were associated with influenza A; younger age and respiratory rate were linked to HPIV-3.

Conclusions:

  • RSV and influenza are important pathogens in pediatric pneumonia in Ecuador.
  • Modifiable risk factors like undernutrition are significant.
  • The findings support the potential future use of an RSV vaccine.
Abstract

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
979